] with our chip data indicates a clear correlation. K) Scatter plot showing the correlation between the motif activities of 503 transcription factors in high glucose (HG) and low glucose (LG) conditions. L) Transcription factors with the largest differences in motif activities between glucose levels are indicated. M) Activity of candidate transcription factors with known importance in islet function. Note that activity signatures of transcription factors involved in β ‐cell stress are induced while motifs associated with pancreatic differentiation are overall decreased. Sequence logos show the binding motif of the respective transcription factor. RNA‐Seq data was analyzed from N = 4 biological replicates. Error bars indicate SEM. *, **, and *** indicate p < 0.05, p < 0.01, and p < 0.001 based on heteroscedastic two‐tailed t ‐tests, respectively. " width="100%" height="100%">
Journal: Advanced Science
Article Title: Bioengineered Pancreas–Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia
doi: 10.1002/advs.202203368
Figure Lengend Snippet: On‐chip exposure of primary human islets to hyperglycemia results in β ‐cell stress, dedifferentiation and islet exhaustion. A) Immunofluorescent staining of primary human islets for insulin ( β ‐cells), glucagon ( α ‐cells), and somatostatin ( δ ‐cells). Dashed line indicates island circumference. Scale bar = 100 µm. B) Expression levels of endocrine hormones secreted by α ‐cells (GCG), β ‐cells (INS), δ ‐cells (SST), γ ‐cells (PPY), and ε ‐cells (GHRL). Expression is shown as log 10 (FPKM) and sorted in descending order. N = 3. C) Quantification of insulin secretion after exposure of islets to hypoglycemic (3.5 m m glucose) or hyperglycemic (11 m m glucose) conditions. For each measurement, 10–20 islets were exposed to the indicated glucose concentrations for 4 h in 120 µL. N = 3. D) Insulin secretion dynamics show that insulin is secreted very rapidly with the bulk of insulin release being detected within the first few minutes after exposure to an increase in glucose concentrations from 3.5 to 11 m m . N = 4. E) Principal component analysis of RNA‐Sequencing data show that isogenic islets exposed to low glucose (LG; 3.5 m m ) and high glucose (HG; 11 m m ) conditions rapidly alter their transcriptomic signatures. F) Left: heatmap visualization of differentially expressed genes. Right: dot plot visualization of Reactome pathway analysis of the indicated clusters. Dot size indicates the number of pathway‐associated genes in the respective cluster; dot color indicates the statistical strength of the association. G) Volcano plot showing the changes in gene expression expressed as fold‐change (FC) of high glucose compared to low glucose. H) The most highly up‐ and downregulated genes include various metabolic modulators, such as the glucose transporter SLC5A9 or the lipid regulator PCSK4 , as well as the proinflammatory chemokine CCL15 . I) The on‐chip glucose response closely resembles response signatures of primary human islets based on established candidate markers. J) Comparison of differentially expressed genes identified in chronic hyperglycemia [ 49 ] with our chip data indicates a clear correlation. K) Scatter plot showing the correlation between the motif activities of 503 transcription factors in high glucose (HG) and low glucose (LG) conditions. L) Transcription factors with the largest differences in motif activities between glucose levels are indicated. M) Activity of candidate transcription factors with known importance in islet function. Note that activity signatures of transcription factors involved in β ‐cell stress are induced while motifs associated with pancreatic differentiation are overall decreased. Sequence logos show the binding motif of the respective transcription factor. RNA‐Seq data was analyzed from N = 4 biological replicates. Error bars indicate SEM. *, **, and *** indicate p < 0.05, p < 0.01, and p < 0.001 based on heteroscedastic two‐tailed t ‐tests, respectively.
Article Snippet: Primary human pancreatic islets were commercially acquired from Tissue Solutions (Glasgow, UK).
Techniques: Staining, Expressing, RNA Sequencing, Gene Expression, Comparison, Activity Assay, Sequencing, Binding Assay, Two Tailed Test